0001192482-21-000211.txt : 20210303 0001192482-21-000211.hdr.sgml : 20210303 20210303200150 ACCESSION NUMBER: 0001192482-21-000211 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180112 FILED AS OF DATE: 20210303 DATE AS OF CHANGE: 20210303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fleming Alison B CENTRAL INDEX KEY: 0001640701 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37372 FILM NUMBER: 21711846 MAIL ADDRESS: STREET 1: 780 DEDHAM STREET, SUITE 800 CITY: CANTON STATE: MA ZIP: 02021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC CENTRAL INDEX KEY: 0001267565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 TECHNOLOGY CENTER DRIVE CITY: STOUGHTON STATE: MA ZIP: 02072 BUSINESS PHONE: 781-713-3699 MAIL ADDRESS: STREET 1: 100 TECHNOLOGY CENTER DRIVE CITY: STOUGHTON STATE: MA ZIP: 02072 FORMER COMPANY: FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC DATE OF NAME CHANGE: 20031020 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-01-12 0001267565 COLLEGIUM PHARMACEUTICAL, INC COLL 0001640701 Fleming Alison B C/O COLLEGIUM PHARMACEUTICAL, INC. 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 0 1 0 0 Chief Technical Officer Common Stock 2018-01-12 4 M 0 1747 0.9 A 157911 D Common Stock 2018-01-12 4 S 0 1747 21 D 156164 D Common Stock 2018-01-12 4 M 0 5753 0.48 A 161917 D Common Stock 2018-01-12 4 S 0 5753 21 D 156164 D Common Stock 2018-01-19 4 M 0 64 0.9 A 156228 D Common Stock 2018-01-19 4 S 0 64 23 D 156164 D Common Stock 2018-01-19 4 M 0 1811 0.9 A 157975 D Common Stock 2018-01-19 4 S 0 1811 23 D 156164 D Common Stock 2018-01-19 4 M 0 1449 3.31 A 157613 D Common Stock 2018-01-19 4 S 0 1449 23 D 156164 D Common Stock 2018-05-10 4 S 0 1400 27 D 154764 D Common Stock 2021-03-01 4 S 0 6011 23.36 D 148753 D Stock Option (Right to Purchase) 0.9 2018-01-12 4 M 0 1747 0 D 2019-04-23 Common Stock 1747 64 D Stock Option (Right to Purchase) 0.48 2018-01-12 4 M 0 5753 0 D 2023-01-24 Common Stock 5753 0 D Stock Option (Right to Purchase) 0.9 2018-01-19 4 M 0 64 0 D 2019-04-23 Common Stock 64 0 D Stock Option (Right to Purchase) 0.9 2018-01-19 4 M 0 1811 0 D 2020-02-26 Common Stock 1811 0 D Stock Option (Right to Purchase) 3.31 2018-01-19 4 M 0 1449 0 D 2021-02-08 Common Stock 1449 0 D Certain transactions reported in this Form 4 are late due to an administrative error. The sales reported in these rows were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017. The sale reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2018. The sale reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2020. The option was fully vested and exercisable as of January 12, 2018. The option was fully vested and exercisable as of January 19, 2018. /s/ Paul Brannelly as Attorney-In-Fact For Alison B. Fleming 2021-03-03